Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for GUTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -1.665M
March 31, 2026 21.38M
December 31, 2025 9.458M
September 30, 2025 -3.178M
June 30, 2025 -18.21M
March 31, 2025 6.375M
December 31, 2024 28.42M
September 30, 2024 50.32M
June 30, 2024 70.76M
March 31, 2024 84.18M
December 31, 2023 -325.06M
September 30, 2023 -307.18M
Date Value
June 30, 2023 -292.52M
March 31, 2023
December 31, 2022 -252.32M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 -209.32M
September 30, 2021 -197.41M
June 30, 2021
March 31, 2021
December 31, 2020 -172.72M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Co-Diagnostics, Inc. 12.71M
Spectral AI, Inc. -12.05M
Vaxcyte, Inc. 2.758B
Moderna, Inc. 6.761B
Arrowhead Pharmaceuticals, Inc. 465.53M

Shareholders Equity (Quarterly) Related Metrics